JODI ANN LEWIS: Open Payments
NPI 1194589101 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,509 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $415 |
| E.R. Squibb & Sons, L.L.C. | 3 | $290 |
| Neurocrine BioSciences, Inc. | 4 | $180 |
| ABBVIE INC. | 16 | $138 |
| Alkermes, Inc. | 7 | $110 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: REXULTI, COBENFY, INGREZZA, VRAYLAR, ABILIFY MAINTENA, Auvelity, LYBALVI, FANAPT.
Industry payments across PA — which companies pay providers there.
